Diabetic ketoacidosis in adults - Update of an old complication;Cetoacidose diabética em adultos - Atualização de uma complicação antiga

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 9, 2007, Pages 1434-1447

  Barone, Bianca ^a,b   Rodacki, Melanie ^a   Cenci, Maria Claudia Peixoto ^a   Zajdenverg, Lenita ^a   Milech, Adolpho ^a   De Oliveira, José Egidio P ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Diabetic ketoacidosis; Pathophysiology; Treatment; Type 1 diabetes

Indexed keywords

EID: 38849104326     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000900005     Document Type: Review

References (86)

1. Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290(13):1713-20.
2. English P, Williams G. Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J 2004;80(943):253-61.
3. Sadauskaite-Kuehne V, Samuelsson U, Jasinskiene E, Padaiga Z, Urbonaite B, Edenvall H, et al. Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res Clin Pract 2002;55(3):247-54.
4. Punnose J, Agarwal MM, El KA, Devadas K, Mugamer IT. Childhood and adolescent diabetes mellitus in Arabs residing in the United Arab Emirates. Diabetes Res Clin Pract 2002;55(1):29-33.
5. Rodacki M, Pereira JR, de Oliveira AM, Barone B, Dowell RM, Perricelli P, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract 2007;78(2):259-62.
6. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287(19):2511-8.
7. da Silveira VMF, Menezes AMB, Post CLA, Machado EC. Uma amostra de pacientes com Diabetes tipo 1 no Sul do Brasil. Arq Bras Endocrinol Metab 2001;45(5):433-40.
8. Apud Gomes MB, Aguiar GLK, Marques EP, Sarno EN, Chacra AR. Estudo comparativo de variáveis epidemiológicas em casos múltiplos e esporádicos de Diabetes mellitus do tipo 1. Arq Bras Endocrinol Metab 1996;40:13-5.
9. Campos JJB, Almeida HG, Iochida LC, Franco LJ. Incidência de Diabetes Mellitus insulino-dependente (Tipo 1) na cidade de Londrina, PR, Brasil. Arq Bras Endocrinol Metab 1998;42(1):36-44.
10. th ed. Alexandria: American Diabetes Association, 2004. pp. 127-35.
11. Kreisberg RA. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Intern Med 1978;88(5):681-95.
12. DeFronzo RA, Matsuda M, Barrett E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994;2:209-38.
13. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 1992;40(11):1100-4.
14. Morris LE, Kitabchi AE. Coma in the diabetic. In: Schnatz JD (ed). Diabetes mellitus: Problems in management. Menlo Park: Addison-Wesley, 1982. pp. 243-51.
15. Krentz AJ, Nattrass M. Acute metabolic complications of diabetes: diabetic ketoacidosis, hyperosmolar non-ketotic hyperglicemia and lactic acidosis. In: Pickup JC, Williams G (ed). Textbook of Diabetes. Oxford: Blackwell Science Ltd, 2003. pp. 1-32.
16. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care 1994;17(10):1178-85.
17. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994;43(6):741-5.
18. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44(7):790-5.
19. Guilhem I, Leguerrier AM, Lecordier F, Poirier JY, Maugendre D. Technical risks with subcutaneous insulin infusion. Diabetes Metab 2006;32(3):279-84.
20. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22(11):1779-84.
21. Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 1989;32(7):421-6.
22. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 1996;19(4):324-7.
23. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25(3):593-8.
24. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995;27(3):199-204.
25. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995;18(3):361-76.
26. Egger M, Davey SG, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997;14(11):919-28.
27. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Hyperglycemic crises in diabetes. American Diabetes Association. Position Statement. Diabetes Care 2004; 27(suppl 1):S94-102.
28. Reichard GA Jr, Skutches CL, Hoeldtke RD, Owen OE. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 1986;35(6):668-74.
29. Owen OE, Trapp VE, Skutches CL, Mozzoli MA, Hoeldtke RD, Boden G, et al. Acetone metabolism during diabetic ketoacidosis. Diabetes 1982;31(3):242-8.
30. Beigelman PM. Severe diabetic ketoacidosis (diabetic "coma"). 482 episodes in 257 patients; experience of three years. Diabetes 1971;20(7):490-500.
31. nd ed. New York: John Wiley, 1997. pp. 1215-29.
32. th ed. Amsterdam: Elsevier, 1997. pp. 827-44.
33. Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 1995;79(1):9-37.
34. a ed. Editora Cultura Médica; 1994.
35. Matz R. Hypothermia in diabetic acidosis. Hormones 1972;3(1):36-41.
36. Kamalakannan D, Baskar V, Barton DM, Abdu TA. Diabetic ketoacidosis in pregnancy. Postgrad Med J 2003;79(934):454-7.
37. Umpierrez GE, Watts NB, Phillips LS. Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis. Diabetes Care 1995;18(1):137-8.
38. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000;29(4):683-705.
39. Abrahamson M, Beaser R, Carver C, Cooppan R, Grossman S, Laffel L, et al. Guideline for the management of hyperglicemic emergencies for adults. Última atualização: 2004.
40. Orsini-Federici M, Akwi JA, Canonico V, Celleno R, Ferolla P, Pippi R, et al. Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006;8(1):67-75.
41. Fabietti PG, Canonico V, Orsini FM, Sarti E, Massi BM. Model based study on monitoring ketone bodies to improve safety in intensive insulin therapy. Int J Artif Organs 2006;29(6):596-601.
42. Guerci B, Benichou M, Floriot M, Bohme P, Fougnot S, Franck P, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003;26(4):1137-41.
43. Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM 2004;97(12):773-80.
44. Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 2006;23(3):278-84.
45. Assadi FK, John EG, Fornell L, Rosenthal IM. Falsely elevated serum creatinine concentration in ketoacidosis. J Pediatr 1985;107(4):562-4.
46. Gerard SK, Khayam-Bashi H. Characterization of creatinine error in ketotic patients. A prospective comparison of alkaline picrate methods with an enzymatic method. Am J Clin Pathol 1985;84(5):659-64.
47. a ed. Editora Revinter, 2000.
48. Winter SD, Pearson JR, Gabow PA, Schultz AL, Lepoff RB. The fall of the serum anion gap. Arch Intern Med 1990;150(2):311-3.
49. Sadjadi SA. A new range for the anion gap. Ann Intern Med 1995;123(10):807.
50. Reasner CA, Isley WL. Endocrine emergencies. Recognizing clues to classic problems. Postgrad Med 1997;101(3):231-8, 241.
51. Marinac JS, Mesa L. Using a severity of illness scoring system to assess intensive care unit admissions for diabetic ketoacidosis. Crit Care Med 2000;28(7):2238-41.
52. Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med 1977;297(5):238-41.
53. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004;117(5):291-6.
54. Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 2004;27(8):1873-8.
55. Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 2005;28(8):1856-61.
56. Kitabchi AE, Sacks HS, Young RT, Morris L. Diabetic ketoacidosis: reappraisal of therapeutic approach. Ann Rev Med 1979;30:339-57.
57. Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am 2000;29(4):707-23.
58. Lebovitz HE. Diabetic ketoacidosis. Lancet 1995;345(8952):767-72.
59. Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med 1976;84(6):633-8.
60. Morris LR, Kitabchi AE. Efficacy of low-dose insulin therapy for severely obtunded patients in diabetic ketoacidosis. Diabetes Care 1980;3(1):53-6.
61. Magee MF, Bhatt BA. Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin 2001;17(1):75-106.
62. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001;24(1):131-53.
63. th ed. Philadelphia: Saunders, 1998. pp. 1010-2.
64. Fisken RA. Severe diabetic ketoacidosis: the need for large doses of insulin. Diabet Med 1999;16(4):347-50.
65. Chiasson JL, Ris-Jilwan N, Belanger R, Bertrand S, Beauregard H, Ekoe JM, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ 2003;168(7):859-66.
66. Trachtenbarg DE. Diabetic ketoacidosis. Am Fam Physician 2005;71(9):1705-14.
67. th ed. Philadelphia: Lea & Febiger, 1994. pp. 738-70.
68. Riley LJ Jr, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: biochemical, physiologic, and clinical perspectives. Diabetes Metab Rev 1989;5(8):627-36.
69. Soler NG, Bennett MA, Dixon K, FitzGerald MG, Malins JM. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet 1972;2(7779):665-7.
70. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986;105(6):836-40.
71. Posner JB, Plum F. Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med 1967;277(12):605-13.
72. Thompson CH, Syme PD, Williams EM, Ledingham JG, Radda GK. Effect of bicarbonate administration on skeletal muscle intracellular pH in the rat: implications for acute administration of bicarbonate in man. Clin Sci (Lond) 1992;82(5):559-64.
73. Ritter JM, Doktor HS, Benjamin N. Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 1990;335(8700):1243-6.
74. Bellingham AJ, Detter JC, Lenfant C. The role of hemoglobin affinity for oxygen and red-cell 2,3-diphosphoglycerate in the management of diabetic ketoacidosis. Trans Assoc Am Physicians 1970;83:113-20.
75. Matz R. Rationale for not using bicarbonate. N Y State J Med 1976;76(8):1299-303.
76. Wilson HK, Keuer SP, Lea AS, Boyd AE III, Eknoyan G. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 1982;142(3):517-20.
77. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983;57(1):177-80.
78. Cefalu WT. Diabetic ketoacidosis. Crit Care Clin 1991;7(1):89-108.
79. Troy PJ, Clark RP, Kakarala SG, Burns J, Silverman IE, Shore E. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care 2005;2(1):55-8.
80. Glaser NS, Wootton-Gorges SL, Marcin JP, Buonocore MH, Dicarlo J, Neely EK, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 2004;145(2):164-71.
81. Lam TI, Anderson SE, Glaser N, O'Donnell ME. Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. Diabetes 2005;54(2):510-6.
82. Isales CM, Min L, Hoffman WH. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications 1999;13(2):91-7.
83. a ed. Rio de Janeiro: Atheneu, 1998. pp. 491-8.
84. Melo MS, de Lolio CA, Lucena MA, Kirzner CF, Martins SM, Barros MN. Causas múltiplas de morte em diabéticos no Município de Recife, 1987. Rev Saude Publica 1991; 25(6):435-42.
85. Franco LJ, Mameri C, Pagliaro H, Iochida LC, Goldenberg P. [Diabetes as primary or associated cause of death in the state of Sao Paulo, Brazil, 1992]. Rev Saude Publica 1998;32(3):237-45.
86. de Lima AK, Schmidt MI, Duncan BB. Mortalidade por complicaç ões agudas do Diabetes Mellitus: um bom indicador de saúde para o Brasil? Cad de Saúde Pública 2006; (in press).